Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Rosenthal

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Cancer Medicine|July 20, 2024
Phase 1 dose escalation study of the MDM2 inhibitor milademetan as monotherapy and in combination with azacitidine in patients with myeloid malignanciesCourtney D DiNardo, Rebecca Olin, Eunice S Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 23, 2018
Late Mortality after Allogeneic Bone Marrow Transplantation in Childhood for Bone Marrow Failure Syndromes and Severe Aplastic AnemiaAnna Sällfors Holmqvist, Yanjun Chen, Jessica Wu, et al.
Frontiers in Oncology|September 23, 2022
Development and characterization of a preclinical total marrow irradiation conditioning-based bone marrow transplant model for sickle cell diseaseSrideshikan Sargur Madabushi, Raghda Fouda, Hemendra Ghimire, et al.
Blood|December 15, 2005
Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapyLisa Marie Serrano, Timothy Pfeiffer, Simon Olivares, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 30, 2020
Reactivation of human herpesvirus 6 in pediatric allogeneic hematopoietic stem cell transplant recipientsAnna B Pawlowska, Nicole A Karras, Huaying Liu, et al.
Transfusion|November 22, 2011
Analysis of 120 pediatric patients with nonmalignant disorders transplanted using unrelated plasma-depleted or -reduced cord bloodLawrence Petz, Tang-Her Jaing, Joseph Rosenthal, et al.
Archives of Physical Medicine and Rehabilitation|July 28, 2015
Predictors of Agitated Behavior During Inpatient Rehabilitation for Traumatic Brain InjuryJennifer Bogner, Ryan S Barrett, Flora M Hammond, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2008
Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse ratesRyotaro Nakamura, Nademanee Auayporn, David D Smith, et al.
Blood|December 8, 2009
A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimensRoberto Rodriguez, Ryotaro Nakamura, Joycelynne M Palmer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 23, 2020
Developing and Monitoring a Standard-of-Care Chimeric Antigen Receptor (CAR) T Cell Clinical Quality and Regulatory ProgramSylvia O Dulan, Kathie L Viers, Jamie R Wagner, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Cancer Medicine|July 20, 2024
Phase 1 dose escalation study of the MDM2 inhibitor milademetan as monotherapy and in combination with azacitidine in patients with myeloid malignanciesCourtney D DiNardo, Rebecca Olin, Eunice S Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 23, 2018
Late Mortality after Allogeneic Bone Marrow Transplantation in Childhood for Bone Marrow Failure Syndromes and Severe Aplastic AnemiaAnna Sällfors Holmqvist, Yanjun Chen, Jessica Wu, et al.
Frontiers in Oncology|September 23, 2022
Development and characterization of a preclinical total marrow irradiation conditioning-based bone marrow transplant model for sickle cell diseaseSrideshikan Sargur Madabushi, Raghda Fouda, Hemendra Ghimire, et al.
Blood|December 15, 2005
Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapyLisa Marie Serrano, Timothy Pfeiffer, Simon Olivares, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 30, 2020
Reactivation of human herpesvirus 6 in pediatric allogeneic hematopoietic stem cell transplant recipientsAnna B Pawlowska, Nicole A Karras, Huaying Liu, et al.
Transfusion|November 22, 2011
Analysis of 120 pediatric patients with nonmalignant disorders transplanted using unrelated plasma-depleted or -reduced cord bloodLawrence Petz, Tang-Her Jaing, Joseph Rosenthal, et al.
Archives of Physical Medicine and Rehabilitation|July 28, 2015
Predictors of Agitated Behavior During Inpatient Rehabilitation for Traumatic Brain InjuryJennifer Bogner, Ryan S Barrett, Flora M Hammond, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2008
Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse ratesRyotaro Nakamura, Nademanee Auayporn, David D Smith, et al.
Blood|December 8, 2009
A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimensRoberto Rodriguez, Ryotaro Nakamura, Joycelynne M Palmer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 23, 2020
Developing and Monitoring a Standard-of-Care Chimeric Antigen Receptor (CAR) T Cell Clinical Quality and Regulatory ProgramSylvia O Dulan, Kathie L Viers, Jamie R Wagner, et al.
Pageof 8